Industry | 2016.03.24
China-Based Biotech Selects Medidata Technology Platform to Simplify Complexity in Oncology R&D
NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its industry-leading technology platform has been adopted by China-based Shanghai Henlius Biotechnology Co. Ltd (“Henlius”). Focused on monoclonal antibody drug development, Henlius is utilizing the Medidata Clinical Cloud® platform to bring operational efficiencies to its complex Phase III oncology clinical trial in China. “To meet
For more information, please visit
http://www.businesswire.com/news/home/20[...]a-Technology-Platform-Simplify
